Vigil Financial Statements From 2010 to 2026
| VIGLDelisted Stock | USD 8.05 0.00 0.00% |
Check Vigil Neuroscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vigil Neuroscience's main balance sheet or income statement drivers, such as , as well as many indicators such as . Vigil financial statements analysis is a perfect complement when working with Vigil Neuroscience Valuation or Volatility modules.
Vigil |
Vigil Neuroscience Company Return On Equity Analysis
Vigil Neuroscience's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vigil Neuroscience Return On Equity | -1.46 |
Most of Vigil Neuroscience's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vigil Neuroscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Vigil Neuroscience has a Return On Equity of -1.4568. This is 93.92% lower than that of the Biotechnology sector and 96.0% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Vigil Neuroscience Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vigil Neuroscience's current stock value. Our valuation model uses many indicators to compare Vigil Neuroscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vigil Neuroscience competition to find correlations between indicators driving Vigil Neuroscience's intrinsic value. More Info.Vigil Neuroscience is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Vigil Neuroscience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Vigil Neuroscience Financial Statements
Vigil Neuroscience investors utilize fundamental indicators, such as revenue or net income, to predict how Vigil Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Vigil Neuroscience, Inc. operates as a subsidiary of Amgen Inc. Vigil Neuroscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Vigil Stock
If you are still planning to invest in Vigil Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vigil Neuroscience's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |